Navigation Links
Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration
Date:6/19/2008

are not limited to, those related to the potential development and commercialization of new products under the Wyeth collaboration agreement. These statements are based on current expectations and assumptions regarding future events and business performance and involve certain risks and uncertainties that could cause actual results to differ materially. These risks include, but are not limited to, risks associated with the company's Wyeth collaboration, including Wyeth's control over development timelines and the risks that the Company is unable to advance its clinical development programs and regulatory applications and action at the rate it expects and such other risks as identified in the company's quarterly report on Form 10-Q for the period ended March 31, 2008, and from time to time in other reports filed by Trubion with the U.S. Securities and Exchange Commission. These reports are available on the Investors page of the company's corporate Web site at http://www.trubion.com. Trubion undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company's expectations.

TRBN-G

Contact:

Jim DeNike

Senior Director, Corporate Communications

Trubion Pharmaceuticals Inc.

(206) 838-0500

jdenike@trubion.com

Waggener Edstrom Worldwide Healthcare

Amy Petty

Senior Account Executive

(617) 576-5788

amyp@waggeneredstrom.com


'/>"/>
SOURCE Trubion Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Trubion Pharmaceuticals Announces Presentation of Positive TRU-015 and SBI-087 Data at the 2008 Annual European Congress of Rheumatology Meeting
2. Trubion Announces Presentation of Positive TRU-016 Data at ASCO
3. Trubion Announces Initiation of Phase 2b Study of TRU-015 for the Treatment of Rheumatoid Arthritis
4. Trubion Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Rheumatoid Arthritis
5. Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update
6. Trubion Announces Initiation of Phase I/II Clinical Trial of TRU-015 for the Treatment of B-Cell Non-Hodgkins Lymphoma
7. Trubion Pharmaceuticals Announces Presentation of Positive Data From Phase IIb and Re-treatment Studies With TRU-015 in Patients With Rheumatoid Arthritis
8. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
9. Peregrine Pharmaceuticals Awarded Two New U.S. Patents Broadening Its Targeted Anti-Phospholipid Patent Portfolio
10. Quatrx Pharmaceuticals Presents Results From Ophena(TM) (Ospemifene Tablets) Phase 3 Study Related to Treatment of Symptoms of Vulvovaginal Atrophy
11. Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Ltd. (NASDAQ: SVA ), a leading provider of biopharmaceutical ... of the Company,s 2014 Annual General Meeting of Shareholders held on ... The required quorum, a majority of the common shares outstanding, was ... following proposals:  , The re-election of Weidong Yin ... Kenneth Lee and Meng Mei as the Company,s ...
(Date:8/27/2014)... YORK and LONDON , Aug. 27, ... research solutions, MarketResearch.com is pleased to announce the ... Medical Devices Knowledge Center. The Medical ... the latest market research in the healthcare industry. ... reports from industry expert, Kalorama Information, published from ...
(Date:8/26/2014)... -- Intelomed is pleased to announce that Mary ... the Vice President of Clinical Affairs. With over 30 ... industry, Kay,s experience in taking medical technology and associated ... global expansion, is a valuable addition to the Intelomed ... our team, and I am confident her focused and ...
Breaking Medicine Technology:Sinovac Announces Results of 2014 Annual General Meeting of Shareholders 2MarketResearch.com: New Medical Devices Research Reports Added to Kalorama Information Knowledge Center 2MarketResearch.com: New Medical Devices Research Reports Added to Kalorama Information Knowledge Center 3Mary Kay Deck joins Intelomed as Vice President of Clinical Affairs 2
(Date:8/27/2014)... 27, 2014 Will Holbrook, CP LP, ... Will has over 15 years of experience in the ... Rome, Georgia with a Bachelor of Science degree with ... He received his graduate degree in prosthetics at ... to have Will join us at Fourroux,” says Keith ...
(Date:8/27/2014)... (HealthDay News) -- In a new study done from ... your blood pressure steadily increases if you ascend to ... widely used to treat high blood pressure was ineffective ... findings, reported online Aug. 27 in the European ... but those at sea level who have sleep apnea, ...
(Date:8/27/2014)... BESLER Consulting , a leading provider of ... pleased to announce that it has been named to ... The list represents the most comprehensive look at an ... "It's been an exciting year for our company and ... Inc. 5000 list,” said Jonathan Besler, BESLER’s President and ...
(Date:8/27/2014)... IL (PRWEB) August 27, 2014 The ... announce the recipients of the 2014-2016 Basic Research Fellowships ... early career scientists, the ABTA is seeding the field ... to change our understanding of the causes, effects, diagnosis ... selected by a scientific committee based on the potential ...
(Date:8/27/2014)... 2014) An experimental drug designed to help regulate the ... for anemia of inflammation, according to results from the first ... in Blood , the Journal of the ... condition that occurs when red blood cells are in short ... anemia, the body does not get enough oxygen, since there ...
Breaking Medicine News(10 mins):Health News:Everest Study Finds High Altitude Affects Blood Pressure 2Health News:BESLER Consulting Among America’s Fastest Growing Private Companies 2Health News:American Brain Tumor Association Awards New Research Grants to Best and Brightest Investigators 2Health News:American Brain Tumor Association Awards New Research Grants to Best and Brightest Investigators 3Health News:Drug represents first potential treatment for common anemia 2
... Aug. 13 Lilly MDR TB Partnership and Children International ... TB eradication in India. , , ... , Lilly MDR TB Partnership, with the support ... teen community with necessary resources to help reach out to ...
... to perceive feelings, study finds , THURSDAY, Aug. 13 ... to recognize other people,s facial emotions, a new study ... brain activity in 15 abstinent long-term alcoholics while they ... emotional expressions. The brain scans revealed decreased activation in ...
... treatment, prevention and detection behind progress, study finds , ... are declining, especially among younger people, new research shows. ... number one killer in the United States, topping heart ... decreased faster than for cancer. , "Older Americans have ...
... , , , , ... KAD ), a leading provider of home care, medical staffing, and pharmacy services ... ended June 30, 2009. , , For the ... with $26.8 million for the same period last year. Arcadia reported a ...
... , , New England ... Therapeutics Article; UFE Could Decrease Hysterectomy Rate in United States ... Uterine fibroid embolization--a minimally invasive interventional radiology treatment for women that ... highlighted as an appropriate treatment for women in a Clinical Therapeutics ...
... BALTIMORE, Aug. 13 To protect the health of ... and the Greater Baltimore Urban League have joined together to ... American Medical Association. , , In ... minorities, including African Americans, face significant barriers to health care, ...
Cached Medicine News:Health News:'Eli Lilly-Children International' Launches Teen Campaign to Reduce TB Cases in India 2Health News:'Eli Lilly-Children International' Launches Teen Campaign to Reduce TB Cases in India 3Health News:Boozing Blunts Ability to Read Faces 2Health News:Cancer Deaths Declining, Especially Among Young 2Health News:Cancer Deaths Declining, Especially Among Young 3Health News:Arcadia Resources Announces First Quarter Results 2Health News:Arcadia Resources Announces First Quarter Results 3Health News:Arcadia Resources Announces First Quarter Results 4Health News:Arcadia Resources Announces First Quarter Results 5Health News:Arcadia Resources Announces First Quarter Results 6Health News:Arcadia Resources Announces First Quarter Results 7Health News:Arcadia Resources Announces First Quarter Results 8Health News:Arcadia Resources Announces First Quarter Results 9Health News:Arcadia Resources Announces First Quarter Results 10Health News:Arcadia Resources Announces First Quarter Results 11Health News:Arcadia Resources Announces First Quarter Results 12Health News:Arcadia Resources Announces First Quarter Results 13Health News:Arcadia Resources Announces First Quarter Results 14Health News:Arcadia Resources Announces First Quarter Results 15Health News:Interventional Radiology Treatment for Uterine Fibroids: Safe, Nonsurgical Option 2Health News:Interventional Radiology Treatment for Uterine Fibroids: Safe, Nonsurgical Option 3Health News:Interventional Radiology Treatment for Uterine Fibroids: Safe, Nonsurgical Option 4Health News:Interventional Radiology Treatment for Uterine Fibroids: Safe, Nonsurgical Option 5Health News:Leading African American Groups Call On Health Insurers to Dismiss Restrictive Practices 2Health News:Leading African American Groups Call On Health Insurers to Dismiss Restrictive Practices 3
IDS Rapid NF Plus, a microbial identification system....
The Cogent Microbial Luminescence System (MLS) is a superior Rapid microbial detection system for UHT product screening combining proven technology of ATP-bioluminescence with unsurpassed hardware in...
Bax detection system is a fast and accurate test for screening food and environmental samples by breaking them down to genetic level, using the power of the polymerase chain reaction (PCR) to detect ...
A versatile plate washer and/or dispenser that aspirates from the top down without immersing the aspirating tubes in the well, ensuring overflow protection. 5 programmable protocols....
Medicine Products: